Capacity expansion at Active Pharmaceutical Ingredient facility in Lindesnes, Norway, contributes to GE Healthcare’s aim to produce 30 million more doses of contrast media per year by 2025 This step reinforces GE Healthcare’s broader commitment to address growing future demand for contrast media, which it expects to double in the next ten years Lindesnes, 17... Read more
Providing Faster Contract Analysis ServicesShimadzu Techno-Research, Inc. Opens a Contract Laboratory for the Automotive Industry Read more
Delivers Simultaneous Multi-Region Neural Imaging of Free-Behaving Animals BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the signing of the definitive agreement to purchase 100% of the shares of Neurescence Inc., an innovative provider of ultralight fiber-bundle Multiscopes™ for simultaneous multi-region, optical functional neuroimaging. Neurescence’s flagship product Chromatone™ moves illumination and detection hardware off... Read more
BILLERICA, Mass–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on December 16, 2022 to stockholders of record as of December 1, 2022. About Bruker Corporation... Read more